A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease

2016209 citationsJournal Article

Authors

Good health and well-being

Published in: Seminars in Arthritis and Rheumatism

Volume 46, Issue 5, pp. 625-631

Field-Weighted Citation Impact: 14.50